InvestorsHub Logo
Followers 4
Posts 401
Boards Moderated 0
Alias Born 06/09/2011

Re: chilling post# 67628

Tuesday, 06/16/2020 12:03:31 PM

Tuesday, June 16, 2020 12:03:31 PM

Post# of 82980
Take a look at the 2017 3rd qt 10K shows 90.5 million shares outstanding.
Over three years they've increased share count by 9 million shares. Hardly dilutive activity. They've also paid off all convertible debt years ago with Dowling at the helm.
____________________________________________________________________

"Dowling's ONLY concern is raising funds and diluting."
____________________________________________________________________

Your statement is totally false. Dowling is ONLY INTERESTED in leading this company forwarded in the BEST INTEREST of the share owners. Period!

As for the 100 Million "Shelf Registration" Prospectus dated 4/21/2020
This is most likely for raising funds to support clinical trials. This would be dilution but the PPS value would undoubtedly increase as clinical trials commence and thereby counteract any dilution as the companies value increases.

https://ir.cvsciences.com/all-sec-filings?page=10#
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVSI News